Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases

Sponsor

Universidad del Valle, Colombia (Other)

Overall Status

Completed

CT.gov ID

NCT00872365

Collaborator

Fundación FES (Other), Fundación Cardiovascular de Colombia (Other), Instituto Nacional de Salud (Other), University College, London (Other)

320

Enrollment

Location

Arms

Duration (Months)

26.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

At the moment, most of efforts to prevent non-transmissible chronic diseases at population level have been centered in promoting healthful behaviors like physical activity, consumption of fruits and vegetables, and discouraging from the consumption of tobacco and alcohol in adult population, but the results have been little hopeful. In the last years, manifold studies have indicated the relation between metabolic alterations and of the fetal growth with the development of non-transmissible chronic diseases in adult age. More recently, it has been proposed that maternal factors (endothelial function, oxidative stress and alterations in adipokines) and placental ones (mitochondrial dysfunction) are the precursory mechanisms of fetal metabolic alterations and of the later development of non-transmissible chronic diseases. Also, it has been suggested that possibly supplementation with micronutrients and the physical exercise during the gestation can regulate these maternal and placental factors. For the reasons just mentioned, it is necessary to clarify if these proposed factors are related to fetal metabolic alterations and if the supplementation during the gestation with micronutrients and/or the physical exercise can regulate them, which would be an early and novel alternative to fortify the prevention of non-transmissible chronic diseases in the population.

Purpose

To evaluate the effect of associated both the maternal and placental metabolic factors to non-transmissible chronic diseases in newborn.
To evaluate the effect of the physical exercise and the complementation with micronutrients during the pregnancy either in the endothelial function, the levels of adipokines, the oxidative stress of the mother and the newborn, as in the placental mitochondrial function and the anthropometry of newborn.

Condition or Disease	Intervention/Treatment	Phase
Preeclampsia Pregnancy Micronutrients Exercise	Behavioral: Regular aerobic physical exercise Dietary Supplement: Micronutrients Other: Activities of daily living + placebo	N/A

Detailed Description

Hypothesis:

There is correlation between the metabolic factors, related to non-transmissible chronic diseases, of the mother and those of the newborn one.
Supplementation with either micronutrients or physical exercise influence beneficially as much in the endothelial function, oxidative stress, the levels in adipokines of the mother and the newborn one like in the placental mitochondrial function.
The simultaneous intervention with micronutrients or physical exercise produces an additional beneficial effect in the metabolic state of the mother and the newborn one.
The metabolic alterations when being born are not exclusive of newborn with anthropometric measures located either in the inferior or superior percentiles.

Study Design

Study Type:

Interventional

Actual Enrollment :

320 participants

Allocation:

Randomized

Intervention Model:

Factorial Assignment

Masking:

Double (Investigator, Outcomes Assessor)

Primary Purpose:

Basic Science

Official Title:

Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases

Study Start Date :

Mar 1, 2011

Actual Primary Completion Date :

Nov 1, 2011

Actual Study Completion Date :

Mar 1, 2012

Arms and Interventions

Arm	Intervention/Treatment
Other: 1 Regular aerobic physical exercise + placebo	Behavioral: Regular aerobic physical exercise Walking (10 minutes), aerobic exercise (30 minutes), stretching (10 minutes) and relaxation exercise (10 minutes). Exercise will be performed at three sessions per week. All sessions will be supervised by a physical therapist and a physical educator. Other Names: Intervention I
Other: 2 Activities of daily living + Micronutrients	Dietary Supplement: Micronutrients Zinc 30mg, Magnesium 400mg, Beta-carotene 9 mg, Tocopherol 30mg, vitamin C 200mg y Niacin 100mg. Other Names: Intervention II
Other: 3 Regular aerobic exercise + micronutrients	Behavioral: Regular aerobic physical exercise Walking (10 minutes), aerobic exercise (30 minutes), stretching (10 minutes) and relaxation exercise (10 minutes). Exercise will be performed at three sessions per week. All sessions will be supervised by a physical therapist and a physical educator. Other Names: Intervention I Dietary Supplement: Micronutrients Zinc 30mg, Magnesium 400mg, Beta-carotene 9 mg, Tocopherol 30mg, vitamin C 200mg y Niacin 100mg. Other Names: Intervention II
Placebo Comparator: 4 Activities of daily living + placebo	Other: Activities of daily living + placebo Basic activities of daily living (bathing, dressing, eating, walking) without counseling by a physical therapist and prenatal care. Placebo Comparator: Equivalent to placebo (maltodextrin).

Outcome Measures

Primary Outcome Measures

Endothelium-dependent flow mediated dilation [Baseline / week 32-36 of gestation]

Secondary Outcome Measures

Biomarkers of endothelial function in blood from umbilical vein and maternal blood [Baseline / 32-36 weeks gestation and delivery]
Markers of mitochondrial function [Baseline / 32-36 weeks gestation and delivery]
Neonatal and maternal anthropometric indicators [Baseline / 32-36 weeks gestation and delivery]
Quality of life SF-12 [Baseline / 32-36 weeks gestation and delivery]
Functional capacity (VO2max) [Baseline / 32-36 weeks gestation and delivery]

Eligibility Criteria

Criteria

Ages Eligible for Study:

16 Years to 30 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Primiparous women who have not participated in a structured exercise program, including significant amounts of walking for the past four months are eligible for the trial.
Live fetus at the routine ultrasound scan and a normal pregnancy.
Gestational age 16 to 20 weeks
Written informed consent will be obtained from each woman prior to the inclusion in the study.

Exclusion Criteria:

History of high blood pressure
Chronic medical illnesses (cancer, renal, endocrinologic, psychiatric, neurologic, infectious and cardiovascular diseases)
Persistent bleeding after week 12 of gestation
Poorly controlled thyroid disease
Placenta praevia, incompetent cervix, polyhydramnios, oligohydramnios
History of miscarriage in the last twelve months
Diseases that could interfere with participation (following recommendations from ACSM 2000, ACOG 2003).